Skip to Main

Search

Results 361 to 370 of 1,060 for ""

UT Southwestern ranked No. 1 hospital in Dallas-Fort Worth by U.S. News & World Report, adding to multiple recognitions in 2019, adding to multiple recognitions in 2018: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/usnwr-best-hospital-again.html

For a third consecutive year, UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth and No. 2 in Texas, according to U.S. News & World Report’s annual Best Hospitals listings released today.

Transfer RNA regulates messenger RNA degradation: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/nov-transfer-rna-regulates-messenger-rna-degradation.html

Transfer RNA (tRNA), a genetic molecule well known for its contribution in reading the instructions for building proteins, is also key in regulating how long those instructions persist in cells, a new study by UT Southwestern Medical Center researchers shows.

Ticking time bomb: Malaria parasite has its own inherent clock: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/malaria-parasite-has-its-own-inherent-clock.html

The activity of the parasite that causes malaria is driven by the parasite’s own inherent clock.

Experts call for more clinical trials on alcohol use, liver disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/june-clinical-trials-alcohol-use-liver-disease.html

More clinical research is needed to investigate how reducing alcohol consumption in patients with alcohol-related liver disease (ALD) may slow disease progression and improve outcomes, according to an international task force of experts from more than two dozen institutions including UT Southwestern

Simmons Cancer Center, MD Anderson scientists develop artificial intelligence method to predict anti-cancer immunity: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/artificial-intelligence-method-to-predict-anti-cancer-immunity.html

Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.

UT Southwestern women’s groups earn national leadership award: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-yin-womens-groups-earn-national-leadership-award.html

UT Southwestern Medical Center has been recognized for its decades of commitment to developing female leaders in medicine and science and its far-reaching impact in supporting and advancing women’s careers.

UT Southwestern, Children's Health recognized for care of Duchenne muscular dystrophy: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/childrens-health-recognized-for-care-of-duchenne-muscular-dystrophy.html

A joint program of UT Southwestern Medical Center and Children’s Health has been approved as a Certified Duchenne Care Center (CDCC) by Parent Project Muscular Dystrophy (PPMD).

Drug combination fights resistance to lung cancer treatment - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/drug-combination-fights-resistance-to-lung-cancer-treatment.html

A new drug combination discovered by the UT Southwestern Simmons Cancer Center may extend the effectiveness of a lung cancer treatment

Happiness might protect you from gastrointestinal distress!: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/happiness-might-protect-you-from-gastrointestinal-distress.html

Serotonin, a chemical known for its role in producing feelings of well-being and happiness in the brain, can reduce the ability of some intestinal pathogens to cause deadly infections

How an experimental drug reverses fatty liver disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/feb-experimental-drug-reverses-fatty-liver-disease.html

A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyceride production and fatty acid synthesis in liver cells, UT Southwestern Medical Center researchers show in a new study.